ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS · Real-Time Price · USD
1.590
+1.230 (341.05%)
At close: Apr 1, 2025, 4:00 PM
2.190
+0.600 (37.74%)
After-hours: Apr 1, 2025, 7:59 PM EDT

ReShape Lifesciences Market Cap

ReShape Lifesciences has a market cap or net worth of $5.26 million as of April 1, 2025. Its market cap has increased by 37.86% in one year.

Market Cap
5.26M
Enterprise Value
6.11M
1-Year Change
37.86%
Ranking
Category
Stock Price
$1.59

Market Cap Chart

Created with Highcharts 11.4.8Range1 Month1M6 Months6MYear to DateYTD1 Year1Y3 Years3Y5 Years5Y10 Years10YFull HistoryMax3 Apr 20201 Apr 2025Max ▾Jul '20Jan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25020M40M60M5M

Since August 22, 2018, ReShape Lifesciences's market cap has increased from $3.45M to $5.26M, an increase of 52.22%. That is a compound annual growth rate of 6.56%.

History

DateMarket Cap% Change
Apr 1, 20255.26M65.33%
Dec 31, 20243.18M-31.26%
Dec 29, 20234.62M41.89%
Dec 30, 20223.26M-88.83%
Dec 31, 202129.16M47.08%
Dec 31, 202019.83M882.72%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 741.66B
UnitedHealth Group 479.08B
Johnson & Johnson 399.65B
AbbVie 370.64B
Novo Nordisk 302.16B
Abbott Laboratories 230.06B
Merck & Co. 226.74B
AstraZeneca 225.46B
Market Cap Rankings